← FDA Drug Approvals (Drugs@FDA)
ERYTHROMYCIN ETHYLSUCCINATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PH HEALTH · Approved 2019-10-23
Drug application
- FDA Application #
ANDA211991- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ERYTHROMYCIN ETHYLSUCCINATE
- Generic name
- Erythromycin Ethylsuccinate
- Active ingredients
- ERYTHROMYCIN ETHYLSUCCINATE
- Dosage form
- GRANULE
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- PH HEALTH
- First approval
- 2019-10-23
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown